LinkedInXFacebook
Subscribe
Orthopedics This Week
  • My Feed
  • |Posts
  • |Events
  • |MSK Innovations
  • |Power Rankings
  • |Masterclasses
  • |Technology Awards
  • Press Releases
  • |Advertising
  • |Job Board
  • Spine
  • ◆Joints
  • ◆Upper Extremities
  • ◆Foot & Ankle
  • ◆Sports Medicine
  • ◆Pain Mgmt
  • ◆Trauma
  • ◆Biologics
  • ◆Technology
  • ◆People
  • ◆Company News
  • ◆Legal & Regulatory
Home/Spine/5-Year Follow-Up Data for Fusionless Scoliosis Treatment
Spine

5-Year Follow-Up Data for Fusionless Scoliosis Treatment

February 2, 2022 2 min read Premium comments

Advertisement

Secondary#minimallyinvasivetechnique#neuromuscularscoliosis

A minimally invasive fusionless technique can be a good alternative to arthrodesis for neuromuscular scoliosis, according to a new study with 5-year follow-up data.

The study, “Minimally Invasive Surgery for Neuromuscular Scoliosis: Results and Complications at a Minimal Follow-up of 5 Years” is published in the December 2021 issue of the journal Spine.

The researchers collected patient outcome data for a minimally invasive fusionless approach to growing rods for neuromuscular scoliosis that uses.

“Conservative treatment is not effective in progressive neuromuscular scoliosis. Early surgery using growing rods is increasingly advocated to control the deformity while preserving spinal and thoracic growth before arthrodesis. These techniques still provide a high rate of complications,” they wrote.

This alternative approach involves using “a bilateral double rod sliding instrumentation anchored proximally by four hook claws and distally to the pelvis by iliosacral screws via a minimally invasive approach.

Eighty-three patients were included in the final analysis. The researchers collected clinical and radiological data during a follow-up of 5 years. Overall, the mean Cobb angle was stable to 35.0° which corresponded to 61% correction of the initial deformation. Mean pelvic obliquity was 29.6° (0.3° –80.0°) preoperatively and 7.2 (0.2°–23.5°) at final follow-up.

The researchers reported that correction of the hyperkyphosis remained stable, and skeletal maturity was reached in 42 of 83 patients. None of the patients went on to have spinal fusion. The global complication rate was 31. 3%.

“The outcomes of this minimally invasive fusionless technique at 5 years follow-up showed a stable correction of spinal deformities and pelvic obliquity over time, with a reduced rate of complication. The arthrodesis was not required for all patients at skeletal maturity. This technique could be a good alternative to arthrodesis for neuromuscular scoliosis,” the researchers wrote.

Study authors include Mathilde Gaume, M.D., of Necker Hospital, Université de Paris, Assistance Publique Hôpitaux de Paris and Arts et Métiers ParisTech, LBM/lnstitut de Biomécanique Humaine Georges Charpak, Paris, France, Claudio Vergari, M.D., of Arts et Métiers ParisTech, LBM/lnstitut de Biomécanique Humaine Georges Charpak, Paris, France, Neijb Khouri, M.D.., of Necker Hospital, Université de Paris, Assistance Publique Hôpitaux de Paris , Wafa Skalli, M.D., of Arts et Métiers ParisTech, LBM/lnstitut de Biomécanique Humaine Georges Charpak, Paris, France, Christophe Glorion, M.D., of Necker Hospital, Université de Paris, Assistance Publique Hôpitaux de Paris and Lotfi Miladi, M.D. of Necker Hospital, Université de Paris, Assistance Publique Hôpitaux de Paris.

React:

Discussion

14
DS
Dr. Sarah MitchellOrthopedic Surgeon · Mayo Clinic

This is a fascinating development. In my practice we've seen similar outcomes with the revised protocol. The key differentiator seems to be patient selection criteria. Has anyone else noticed the correlation with BMI thresholds?

8
JT
James Thornton, MDSpine Fellow · HSS

Great point. I'd push back slightly on the conclusion, the sample size in the cited study is too small to draw population-level inferences. That said, the directional signal is compelling and worth a larger RCT.

5
RP
R. PatelSports Medicine · Stanford

We implemented a similar approach last year. Early results are promising but we're still gathering 12-month follow-up data. Happy to share our protocol if anyone is interested.

Join the conversation

Orthopedic professionals are discussing this. Sign in and upgrade to read every comment and add your voice.

Subscribe

Get Full Access

Read every OTW article and join member discussions for $24.99/month.

Get Full Access

Advertisement

Advertisement

Advertisement

Orthopedics This Week

The most trusted source in orthopedic industry news since 2005. Covering spine, joints, trauma, biologics, and the business of orthopedics.

A publication of RRY Publications, LLC

LinkedInXFacebook

Categories

  • Spine
  • Joints
  • Upper Extremities
  • Foot & Ankle
  • Sports Medicine
  • Pain Mgmt
  • Trauma
  • Biologics
  • Technology
  • People
  • Company News
  • Legal & Regulatory

Resources

  • Subscribe
  • Community Posts
  • Job Board
  • Press Release Opportunities
  • Power Rankings
  • About OTW
  • Advertise
  • Contact Us

Get Full Access

Unlimited articles, community posts, and Power Rankings.

Get Full Access

Plans start at $24.99/mo · Annual saves 20%

© 2026 Orthopedics This Week · RRY Publications, LLC

Privacy PolicyTerms of ServiceCookie Policy